Aurora Cannabis (ACB) Asset Utilization Ratio (2018 - 2026)
Aurora Cannabis (ACB) posted quarterly Asset Utilization Ratio of 0.61 for Q1 2026, down 20.8% year-on-year from 0.77 in Q1 2025, and up 14.25% on a QoQ basis from 0.54 in Q4 2025.
Aurora Cannabis (ACB) Asset Utilization Ratio (2018 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Asset Utilization Ratio for 9 consecutive years, with 0.61 the latest figure, recorded in Q1 2026.
- Quarterly Asset Utilization Ratio fell 20.8% year-over-year to 0.61 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.61 (down 20.8% YoY) and the FY2026 annual result came in at 0.44, up 31.58% from the prior year.
- Asset Utilization Ratio improved to 0.61 in Q1 2026 per ACB's latest filing, from 0.54 in the prior quarter.
- Over the last five years, Asset Utilization Ratio for ACB reached as high as 1.74 in Q3 2023 and fell as low as 0.01 in Q1 2022.
- A 5-year average of 0.77 and a median of 0.66 in 2024 frame the typical range for Asset Utilization Ratio.
- The largest YoY upside for Asset Utilization Ratio was 5174.82% in 2022 against a maximum downside of 111.05% in 2022.
- Year by year, Asset Utilization Ratio stood at 0.33 in 2022, then jumped by 419.3% to 1.72 in 2023, then tumbled by 57.54% to 0.73 in 2024, then declined by 26.63% to 0.54 in 2025, then gained by 14.25% to 0.61 in 2026.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.61, 0.54, and 0.48 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 0.43 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 0.62 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 0.46 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.43 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.39 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.65 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 0.37 |
| 10 | Aurora Cannabis | 1.11 Bn | 1.03 Bn | 21.72 Mn | 0.61 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.61 |
| Dec 31, 2025 | 0.54 |
| Sep 30, 2025 | 0.48 |
| Jun 30, 2025 | 0.57 |
| Mar 31, 2025 | 0.77 |
| Dec 31, 2024 | 0.73 |
| Sep 30, 2024 | 0.71 |
| Jun 30, 2024 | 1.16 |
| Mar 31, 2024 | 1.59 |
| Dec 31, 2023 | 1.72 |
| Sep 30, 2023 | 1.74 |
| Jun 30, 2023 | 1.06 |
| Dec 31, 2022 | 0.33 |
| Sep 30, 2022 | 0.23 |
| Jun 30, 2022 | 0.17 |
| Mar 31, 2022 | -0.01 |
| Dec 31, 2021 | -0.01 |
| Sep 30, 2021 | 0.00 |
| Jun 30, 2021 | 0.00 |
| Mar 31, 2021 | 0.10 |